SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-24-000096
Filing Date
2024-10-03
Accepted
2024-10-03 16:11:52
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3562
  Complete submission text file 0001735276-24-000096.txt   5172
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FOUNDATION MEDICINE, INC. ONE KENDALL SQUARE, SUITE B3501 CAMBRIDGE MA 02139
Business Address
Hesslein Robert W. (Reporting) CIK: 0001585018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 241351600